Search
Search Results
-
iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease
1375PDF: 2562Supplementary: 321Appendix: 268 -
Lipoprotein(a): what clinicians need to know
402PDF: 750HTML: 24 -
The effect of SGLT2 inhibitors on health status in patients with heart failure: a systematic review and meta-analysis
2585PDF: 672Conflict of interest: 322SUPPLEMENTARY MATERIAL: 261HTML: 64 -
Sex differences in clinical characteristics and outcomes in heart failure with mildly reduced and preserved ejection fraction
812PDF: 199Supplementary: 154Appendix: 106HTML: 39 -
Sex-based differences in characteristics, management, and outcomes in heart failure with reduced ejection fraction
808PDF: 226Supplementary: 146Appendix: 112HTML: 48 -
Modulation of cardiac metabolism in heart failure
2372PDF: 1162HTML: 31 -
The association of iron deficiency with right ventricular dysfunction in Africans with heart failure
2366PDF: 405Appendix B: 438Appendix A: 323HTML: 2 -
The impact of frailty on in-hospital outcomes in patients with HFrEF
209PDF: 71Supplementary: 12HTML: 5 -
Is the obesity paradox present in left ventricular assist device recipients? A BMI-based analysis
200PDF: 244Supplementary: 151HTML: 23 -
SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials
1161pdf: 260Supplementary Material: 41HTML: 129 -
-
Evolving targets for heart failure: the journey so far
2073pdf: 339HTML: 4 -
Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients
1989PDF: 528SUPPLEMENTARY MATERIAL: 302GRAPHICAL ABSTRACT: 265HTML: 31 -
Safety and efficacy of left atrial appendage closure in cancer versus non-cancer patients: a systematic review and meta-analysis
1149PDF: 271Supplementary: 161HTML: 93

